The Biotech Growth Trust PLC

(the "Company")

Result of General Meeting

27 February 2025

Following a General Meeting of the Company held today, the Board is pleased to announce that the special resolution seeking the approval of Shareholders to renew the Company's authority to buy back up to 14.99 per cent. of the Company's issued Share capital, was passed on a show of hands.

The proxy voting figures are shown below:

Special Resolution

Votes For

%

Votes Against

%

Total Votes Cast

Votes

Withheld

1.

8,511,712

99.7

28,426

0.3

8,540,138

22,889

Notes:

Any proxy votes which are at the discretion of the Chair have been included in the "for" total. A vote withheld is not a vote in law and is not counted in the votes for or against a resolution.

At the date and time of the General Meeting, the total number of Ordinary Shares of 25p each in issue and the total number of voting rights was 28,387,591.

The proxy voting figures will shortly be available on the Company's website at www.biotechgt.com

The full text of the special resolution passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The special resolution will additionally be filed with Companies House.

The full text of the resolution can be found in the Notice of General Meeting contained in the Circular dated 3 February 2025 (the "Circular"), which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website, www.biotechgt.com  Capitalised terms used in this announcement shall, unless the context otherwise requires, bear the meanings given to them in the Circular.

Legal Entity Identifier: 549300Z41EP32MI2DN29

Enquiries:

Katherine Manson

Frostrow Capital LLP

Company Secretary

Telephone: 0203 709 8734

THE BIOTECH GROWTH TRUST PLC

LEI:549300Z41EP32MI2DN29

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 26 February 2025 was 902.00p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

27 February 2025

BLOCK LISTING SIX MONTHLY RETURN

Date: 27 February 2025

Name of applicant:

The Biotech Growth Trust PLC

Name of scheme:

General

Period of return:

From:

27 August 2024

To:

26 February 2025

Balance of unallotted securities under scheme(s) from previous return:

3,530,634

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

3,530,634

Name of contact:

Katherine Manson - Frostrow Capital LLP

Telephone number of contact:

020 3709 8734

THE BIOTECH GROWTH TRUST PLC

LEI:549300Z41EP32MI2DN29

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 25 February 2025 was 903.65p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

26 February 2025

THE BIOTECH GROWTH TRUST PLC

LEI:549300Z41EP32MI2DN29

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 24 February 2025 was 920.28p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

25 February 2025

For immediate release

21 February 2025

(the "Company")

MARKET PURCHASE OF COMPANY'S OWN SHARES

Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 4,929,790 that a market total of 111,879 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 841.81 pence per share.

Following this transaction, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 28,387,591. The Company does not currently hold any Ordinary shares in treasury.

The figure of 28,387,591 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Katherine Manson

Frostrow Capital LLP

Tel: 020 3709 8734

THE BIOTECH GROWTH TRUST PLC

LEI:549300Z41EP32MI2DN29

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 20 February 2025 was 933.35p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

21 February 2025

THE BIOTECH GROWTH TRUST PLC

LEI:549300Z41EP32MI2DN29

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 19 February 2025 was 928.72p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

20 February 2025

THE BIOTECH GROWTH TRUST PLC

LEI:549300Z41EP32MI2DN29

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 18 February 2025 was 917.55p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

19 February 2025

THE BIOTECH GROWTH TRUST PLC

LEI:549300Z41EP32MI2DN29

NET ASSET VALUE

The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 17 February 2025 was 925.33p (cum income).

For and on behalf of the Board

Frostrow Capital LLP

Secretary

18 February 2025